C4 Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-07 07:08:00 ET CCCC

Published on 05/07/2025 at 07:08, updated on 05/07/2025 at 08:50

C4 Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 26.32 million compared to USD 28.36 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 0.41 a year ago.

Diluted loss per share from continuing operations was USD 0.37 compared to USD 0.41 a year ago.